ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christopher A. Caldarone
Hani K. Najm
William G. Williams
John G. Coles
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caldarone, C. A.
Right arrow Articles by Coles, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caldarone, C. A.
Right arrow Articles by Coles, J. G.

Ann Thorac Surg 1998;66:1514-1520
© 1998 The Society of Thoracic Surgeons

Relentless pulmonary vein stenosis after repair of total anomalous pulmonary venous drainage

Christopher A. Caldarone, MDa, Hani K. Najm, MDa, Margit Kadletz, MDa, Jeffrey F. Smallhorn, MDa, Robert M. Freedom, MDa, William G. Williams, MDa, John G. Coles, MDa

a Division of Cardiovascular Surgery, The Hospital for Sick Children, University of Toronto and University of Toronto Faculty of Medicine, Toronto, Canada

Address reprint requests to Dr Caldarone, Division of Cardiovascular Surgery, The Children’s Hospital of Iowa at the University of Iowa Hospitals and Clinics, 200 Hawkins Dr 1616A JCP, Iowa City, IA 52242-1083
e-mail: (Chris-Caldarone{at}UIowa.edu)

Presented at the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 26–28, 1998.


    Abstract
 Top
 Footnotes
 Abstract
 Introduction
 Methods
 Results
 Comment
 References
 
Background. Progressive stenosis of the pulmonary veins after repair of total anomalous pulmonary venous drainage is frequently refractory to surgical therapy.

Methods. Retrospective review of 170 consecutive patients treated for total anomalous pulmonary venous drainage identified 13 patients with postrepair pulmonary vein stenosis. Preoperative and operative data were analyzed to define the patterns of progression and efficacy of surgical techniques.

Results. Seventeen reoperations were performed in 13 patients. Postrepair pulmonary vein stenosis was most common in the infracardiac and mixed subtypes (p < 0.02). All 4 patients with unilateral stenosis, 2 of whom had progression of stenosis resulting in nearly complete unilateral pulmonary vein occlusion, survived. Six of 9 patients with bilateral disease died (p < 0.05 versus unilateral); 2 of the 3 survivors were repaired with a novel technique creating a sutureless neoatrium without evidence of restenosis at 1.8 years’ follow-up. Stenting was uniformly unsuccessful.

Conclusions. In unilateral stenosis, progression of disease may be survivable with loss of single-lung perfusion. Although bilateral disease is lethal in most cases, creation of a sutureless neoatrium has demonstrated short-term freedom from disease progression.


    Introduction
 Top
 Footnotes
 Abstract
 Introduction
 Methods
 Results
 Comment
 References
 
Total anomalous pulmonary venous drainage (TAPVD) is a relatively rare form of congenital heart disease, typically presenting in the absence of other cardiac anomalies. Despite the relatively straightforward characteristics of this anatomic lesion, there is a low but persistent incidence of postrepair pulmonary vein stenosis (PR-PVS), even after uneventful repair. Recurrence is typically soon after initial repair and rapidly progresses with pulmonary venous thickening and fibrosis, often diffusely through the pulmonary parenchyma. Previous reports have described mortality rates of 37% to 100% for small groups of patients with PR-PVS [13], although a few studies have focused exclusively on the group of patients with recurrent stenosis after total anomalous vein repair.

In this report, the clinical course of 13 patients with PR-PVS after repair of TAPVD is described. Surgical management of this group is analyzed to provide a background against which to compare a novel surgical technique designed to minimize local injury in stenotic pulmonary veins. Specifically, a sutureless technique is described that augments the size of the left atrium while avoiding any suturing of the divided edges of stenotic pulmonary veins. The sutureless neoatrium technique evolved in response to speculation that intraoperative factors (eg, local tissue injury at the site of anastomosis) may stimulate the perpetuation of a progressive fibrotic response that rapidly spreads through the pulmonary veins. The procedure was applied to 2 patients in the high-risk subset of patients returning to the operating room with pulmonary vein stenosis after apparently successful initial repair.


    Methods
 Top
 Footnotes
 Abstract
 Introduction
 Methods
 Results
 Comment
 References
 
Review of the cardiovascular surgical database at the Hospital for Sick Children of Toronto between July 1982 and July 1996 identified 170 patients undergoing primary surgical repair of total anomalous pulmonary venous return. Of these 170 patients, 129 survived more than 30 days after initial repair (24% early mortality). Thirteen of the 129 survivors (10%) experienced PR-PVS, defined as pulmonary vein stenosis requiring intervention and presenting more than 30 days after initial TAPVD repair. These 13 patients are the subject of this retrospectiveanalysis. Patients presenting with pulmonary vein stenosis at less than 30 days after initial repair were considered to be obstructed because of an intraoperative technical error and were excluded from further analysis. Hospital charts, office data, and direct telephone contact were used for follow-up data. Echocardiograms were then reevaluated in a blinded fashion by one of the authors (J.S.). Catheterization data and perfusion scans, when present, were also reviewed.

Surgical technique
To be included in the study, all 13 patients had at least one intervention for PR-PVS. Three patients had a second reoperation, and 1 patient had a third reoperation. Sixteen of the 17 procedures performed were operative repairs. One patient was treated in the catheterization lab with stenting of the left lower pulmonary vein. Four other stenting procedures were performed in the operating room as a component of other procedures. A breakdown of the operative techniques is summarized in Table 1.


View this table:
[in this window]
[in a new window]
 
Table 1. Operative Techniques Used

 
Unroofing of stenoses was the most common of the procedures performed. Stenosed vein anastomoses were divided through the scarring and the fibrous tissue back to a larger caliber vein proximal to the stenosis. When necessary, the surgeon resected fibrous tissue in the area to further open the stenoses. In 6 patients with bilateral stenosis, the left atrial size was considered too small by the surgeon, and the size was augmented by unroofing the coronary sinus in 2 patients or by patching open the atrium with pericardium or prosthetic. An atrial flap venoplasty was performed in 3 patients, using the left atrial appendage to augment a pulmonary venotomy in 2 cases and a flap of right atrium to augment the right pulmonary vein in the other.

In 2 patients with bilateral stenosis, a sutureless neoatrium was constructed. The application and description of the procedure can be illustrated by summarizing the hospital course of the 2 patients in which it was used.

Case 1
Patient 1 presented at 14 days of age with TAPVD to the coronary sinus and clinical evidence of stenosis. On echocardiogram, stenosis was noted at the junction of the pulmonary venous confluence and the coronary sinus with a peak gradient of 14 mm Hg. There was an unrestrictive atrial septal defect and right-sided hypertension (right ventricular systolic pressure, 53 mm Hg; cuff systolic pressure, 60 mm Hg). The patient was brought to the operating room, and the coronary sinus unroofed back to the pulmonary venous confluence; a pericardial patch was used to close the remaining atrial septal defect. After the repair, the patient had severe pulmonary hypertension and ultimately required extracorporeal membrane oxygenation support for 48 hours, after which the cannulas were successfully removed from the patient. Residual pulmonary vein stenosis was noted on postoperative day 9. Although the patient had a prolonged stay in the intensive care unit, she was discharged after 6 weeks.

The patient was noted to have progression of right pulmonary vein stenosis by echocardiogram within 8 months, associated with failure to thrive. Perfusion scan demonstrated 87% flow to the left lung and 13% to the right lung. Echocardiogram 2 months later demonstrated bilateral pulmonary vein stenosis. Subsequent catheterization demonstrated right ventricular pressures that were one-half systemic and pulmonary wedge pressures that were 26 mm Hg on the right and 16 mm Hg on the left. Severe stenosis of the right pulmonary veins as well as moderate stenosis of the left pulmonary veins was noted.

The patient was brought to the operating room and was noted to have severe bilateral PR-PVS occurring at the junction of the pulmonary vein and the left atrium with extension of the thickened intima into the lung parenchyma.

Repair was accomplished with the sutureless neoatrium technique while under total circulatory arrest. Working from inside the left atrium, the common orifice to the left upper and lower pulmonary veins was opened with extension of the venotomies into the upper and lower branches. The pericardium (in situ) was then sutured to the left atrium at a distance from the pulmonary vein incisions, thereby creating a "controlled bleed" into a "neo" left atrium. There were no sutures placed in the incised pulmonary veins themselves. A similar procedure was used on the nearly atretic right-side pulmonary veins (Fig 1).



View larger version (17K):
[in this window]
[in a new window]
 
Fig 1. The sutureless neoatrium is constructed through a left atriotomy. (A) The dashed lines represent the incision across the left atrium and through the stenotic segments of the upper and lower pulmonary veins (cross-hatched areas). (B) The unroofed stenoses are illustrated. The neoatrium is created by suturing the pericardium to the lateral wall of the atria along a suture line distant from the divided edges of the pulmonary veins. (C) The anastomosis is completed, creating continuity between the pulmonary veins and the left atrium without direct suturing of the pulmonary veins (eg, a "controlled bleed"). The procedure is repeated on the contralateral side if indicated. (AO = aorta; SVC = superior vena cava; IVC = inferior vena cava.) (Reprinted from Najm HK, Caldarone CA, Kadletz M, et al. A sutureless technique for the relief of pulmonary vein stenosis with the use of in situ pericardium. J Thorac Cardiovasc Surg 1998;115(2):468–70, by permission of Mosby, Inc.

 
Postoperatively, the patient’s course was unremarkable. Catheterization at 59 days postoperatively demonstrated no evidence of obstruction. Pulmonary artery pressure was less than 25% systemic pressure. The left pulmonary artery wedge pressure was 6 mm Hg, whereas the right pulmonary artery wedge pressure remained elevated at 22 mm Hg. A perfusion scan at 343 days postoperatively demonstrated 42% of flow to the left lung and 58% to the right lung. Echocardiogram at 1.4 years after repair demonstrated phasic flow in all pulmonary veins without evidence of obstruction. Clinically the patient is asymptomatic and growing well at 1.8 years after repair.

Case 2
Patient 2 presented at birth with obstructed infradiaphragmatic TAPVD and cyanosis. On exploration in the operating room, the pulmonary veins were noted to drain to a vertically oriented confluence that drained below the diaphragm. Under total circulatory arrest, the confluence was anastomosed to the posterior left atrium using continuous Prolene (Ethicon, Somerville, NJ) sutures, the left atrium was enlarged with an autologous pericardial patch, and the descending vertical vein was ligated. Postoperative transesophageal echocardiogram demonstrated no evidence of obstruction. Pulmonary artery pressures, however, remained suprasystemic despite vasodilator and nitric oxide therapy.

By 4 months of age, the patient had clinical evidence of right ventricular hypertension and failure to thrive. Catheterization demonstrated bilateral pulmonary venous obstruction at the junction with the atrium, worse on the left than on the right. The left upper pulmonary vein was completely obstructed. Pulmonary artery pressures were approximately 66% of systemic pressure. At operation, circumferential fibrous stenosis was noted at the orifice of all four pulmonary veins. The repair was made by unroofing all four pulmonary veins. A pedicled flap of right atrium was used to augment the caliber of the right and left upper veins. The left atrial appendage was used as a patch to augment the size of the left lower pulmonary vein.

Echocardiogram at 1 month postoperatively demonstrated no evidence of pulmonary vein stenosis. At 4 months postoperatively, however, the patient was noted to have turbulent flow in all pulmonary veins with a mean gradient of 11 mm Hg on the right and 7 mm Hg on the left. Subsequent catheterization demonstrated nearly complete obstruction of all pulmonary veins and reactive pulmonary hypertension. Pulmonary artery pressures were again approximately 66% of systemic pressure.

At 1 year of age, the patient was again returned to the operating room. Severe stenosis was noted at the origin of all pulmonary veins. Under total circulatory arrest, the strictured pulmonary vein segments were unroofed and the incisions carried into the left atrium. The surrounding in situ pericardium was then sutured to the left atrium, creating a controlled bleed through the incised pulmonary veins into the neoatrial chamber. Again, there were no sutures placed in the incised edges of the pulmonary veins. Pulmonary artery pressures were approximately 50% of systemic pressure at the end of the operation.

Lung perfusion scan at 1 year demonstrated 33% flow to the left lung and 67% flow to the right lung. The patient is clinically asymptomatic. Echocardiogram 1.6 years after repair demonstrated mild 1+ bilateral obstruction with low right ventricular pressures. Clinically, at 1.8 years after repair, the patient is asymptomatic.


    Results
 Top
 Footnotes
 Abstract
 Introduction
 Methods
 Results
 Comment
 References
 
A total of 170 patients were identified with TAPVD. Of this group, 129 survived more than 30 days after repair, and of these survivors, 13 patients had recurrent pulmonary vein stenosis. The anatomic breakdown of the entire cohort and the patients with pulmonary vein stenosis is summarized in Table 2. Within the smaller group of 13 patients with PR-PVS, the infracardiac and mixed subtypes were most common (p < 0.05). Of note, 1 of the 2 patients with a mixed subtype who had recurrent stenosis had infracardiac drainage, further supporting a preponderance of recurrent stenoses in the infracardiac subgroup.


View this table:
[in this window]
[in a new window]
 
Table 2. Anatomic Subtypes

 
Survival among the entire group of 170 patients is presented in Fig 2. Although early (< 30 days) mortality was 24%, there were few deaths beyond the early perioperative period (10-year actuarial survival, 59%). When the entire group of 170 patients was further subdivided into anatomic subtypes, there were no statistically significant differences in actuarial survival between the different subtypes (p = 0.29). Among the 13 patients with PR-PVS, there was not a statistically significant difference in the number of survivors in any anatomic subgroup (Table 3).



View larger version (10K):
[in this window]
[in a new window]
 
Fig 2. Survival after initial repair of total anomalous pulmonary venous return for all patients (n = 170).

 

View this table:
[in this window]
[in a new window]
 
Table 3. Status at Follow-Up

 
The average age at the original presentation for TAPVD repair was 14.9 ± 17.9 days. The average age at which the patients returned with PR-PVS was 36.7 ± 27.5 days (range, 54 to 1,660 days); thus, the average interval between the initial TAPVD repair and the intervention for pulmonary vein stenosis was approximately 1 year. Within the group of 13 patients with PR-PVS, survivors presented for reoperation within 565 ± 551 days whereas the nonsurvivors presented within 104 ± 80.3 days (p = 0.069 versus survivors). Thus, there was a statistically nonsignificant trend toward more rapid progression of disease in the nonsurvivors.

A similar pattern was found when comparing the age at operation for initial repair grouped by the presence of eventual unilateral versus bilateral pulmonary vein stenosis. There was no statistical difference in the age at original presentation for the patients who would eventually progress to unilateral or bilateral stenosis. When comparing the interval to intervention for PR-PVS, however, the patients with bilateral stenosis presented after a shorter interval (141 ± 112 days) compared with the patients with unilateral stenosis (828 ± 615 days, p = 0.0059 versus bilateral). Thus, the clinical progression of disease in patients with ultimately bilateral pulmonary vein stenosis was more rapid.

Actuarial survival was 51% at 10 years for patients with PR-PVS (Fig 3). When perioperative (<30 days) mortality is excluded, there was a statistically significant difference in survival between the total group of patients with TAPVD (n = 170) and the 13 patients with PR-PVS (p < 0.001) (Fig 4).



View larger version (12K):
[in this window]
[in a new window]
 
Fig 3. Survival of patients after intervention for postrepair pulmonary vein stenosis (n = 13).

 


View larger version (13K):
[in this window]
[in a new window]
 
Fig 4. Survival after repair of total anomalous pulmonary venous drainage with early (<30 days) mortality excluded for patients with and without subsequent postrepair pulmonary vein stenosis (p < 0.001).

 
All 4 patients with unilateral restenosis were alive at follow-up. Two of these 4 patients, however, have had progression of their unilateral disease, resulting in nearly completely (7% of pulmonary flow) or complete (0% pulmonary flow) pulmonary vein occlusion in the affected lung documented by lung perfusion scan. The perfusion scans were performed at 771 and 891 days after operation for PR-PVS.

In contrast to patients with unilateral stenosis, 6 of 9 patients with bilateral pulmonary vein stenosis died during the follow-up period (p < 0.05 versus unilateral stenosis). Of the 3 survivors, 2 underwent the sutureless neoatrium repair. The other survivor presented with mixed drainage, with infracardiac drainage to the left lung through a vertical confluence and right lung draining through the superior vena cava–right atrium junction. The right lung drainage had been decompressed with a baffle through an enlarged atrial septal defect. When stenosis developed, the left pulmonary anastomosis developed a diffuse fibrotic response. The right-sided portion of this bilateral stenosis, however, was limited to obstruction within the baffle. Although this patient is classified as having bilateral stenosis, scarring and fibrosis within the right-sided pulmonary veins was not observed. This patient’s most recent lung perfusion scan at 1,172 days postoperatively demonstrated 45% flow to the left lung and 55% to the right lung. The patient is entirely asymptomatic.

Five pulmonary vein stenting procedures were performed in 4 patients. Three of these 4 patients had bilateral stenosis and had bilateral stents placed. A fourth patient had a unilateral stent placed. Turbulent flow was present in all stented veins by postoperative Doppler echocardiography. All stented veins progressed to lethal bilateral stenosis (n = 3) or near complete unilateral pulmonary vein occlusion (n = 1).

Catheterization data before repair for PR-PVS were complete for 9 of the 13 patients. Of note, the ratio of pulmonary artery to systemic pressure tended to be higher in the nonsurvivors (0.71 ± 0.23 versus 0.46 ± 0.11). This difference, however, did not reach statistical significance (p = 0.08).

Median follow-up in the 13 cases of PR-PVS (100% complete) was 6.7 years. For the entire series (n = 170), the median follow-up was 4.7 years, and the duration of follow-up was greater than 1 year in 83% of the survivors.


    Comment
 Top
 Footnotes
 Abstract
 Introduction
 Methods
 Results
 Comment
 References
 
Repair of total anomalous pulmonary venous return has been noted by Bando and coworkers [2] to be associated with decreasing perioperative morbidity in more recent years. This improvement in early mortality is thought to reflect evolving management strategies and operative technique. Despite such advances, however, in most series a small but persistent percentage of patients will return after repair with pulmonary vein stenosis. In the series by Bando and associates [2], 99 patients had long-term follow-up, 2 of the 99 died suddenly with pulmonary vein stenosis, and 8 required reoperation for vein stenosis with a 38% reoperative mortality rate. Other authors have reported similar series with an incidence of PR-PVS ranging between 5% and 10% of patients undergoing repair of TAPVD [35]. The mortality within this subset of patients has been reported as high as 100% [3, 5].

Wilson and colleagues [6] have attempted to define variables associated with improved outcome after repair of TAPVD. In their report, the actuarial freedom from restenosis was 82%. By multivariate analysis, the only risk factor for restenosis identified was the use of a type I repair (defined as suturing the common venous chamber directly to the left atrium with continuous suture through an apical or right-sided exposure). A type II repair, which used interrupted suture and a pericardial patch to augment a portion of the left atrial–common venous chamber anastomosis was not identified as a risk factor for restenosis. Interestingly, intraoperative technical details were described as important determinants of recurrent stenosis. The authors speculate that "low grade venous obstruction present at the end of the procedure ... results in reactive fibrosis and self-perpetuating stenosis."

In the present study, we have attempted to define the clinical characteristics of the subset of patients presenting with PR-PVS. These patients presented within a year after their initial repair. More rapid development of PR-PVS is associated with a more rapid progression of diffuse stenotic lesions and early mortality. The presence of bilateral obstructive processes is also associated with the same rapid progression and dismal prognosis. Although the patients with unilateral PR-PVS had 100% survival, 2 of the 4 patients had progression of their unilateral disease to near complete or complete obstruction of the involved pulmonary veins, further emphasizing the relentless nature of the obstructive process.

Previous studies by Smallhorn and associates [7] have noted that the presence of echocardiographically defined turbulence within the pulmonary veins after repair is associated with restenosis. We hypothesize that imperfections in the surgically created venoatrial anastomosis can create local turbulence in some cases. Subsequently, focal injury from the suture line, suture material, or handling of the vein tissue can also serve as a focal point of acute injury. The local tissue injury and anastomotic turbulence is hypothesized to act in combination to generate a progressive upstream cycle of stenosis, increase turbulent flow, and further local injury.

The operative strategy in the present study was designed to minimize trauma at the suture line and avoid postoperative turbulence. By using a sutureless technique, we minimize handling of tissues and avoid any suture-related injury at the anastomosis. Furthermore, the lack of suture in the anastomosis should minimize any deformation of the common pulmonary chamber caused by tension or inflexibility from the suture itself. The pulmonary vein tissue geometry will be imposed nearly completely by the pulmonary vein flow through the anastomosis, rather than by a combination of pulmonary venous flow and the constraints imposed by restrictive characteristics of the suture line. The procedure also augments the size of the left atrium by creating a neoatrium.

Although the sutureless neoatrium technique could be used in routine cases of TAPVD at the original presentation; the relatively low incidence of PR-PVS makes it unlikely to be of easily demonstrable benefit when compared with more commonly used repairs. The subset of patients returning with bilateral postrepair obstruction, however, is a subset with a high rate of recurrent stenosis and poor overall prognosis. Within this subset, we have used the technique in 2 of the 9 patients with bilateral PR-PVS. Both patients, representing 2 of the 3 survivors in this series, are alive at 1.8 years’ follow-up.

In conclusion, PR-PVS can be manifest as a relentlessly progressive diffuse stenotic lesion within the pulmonary veins. Stenting has been uniformly unsuccessful for palliation. The presence of bilateral disease or rapid development of the lesion after initial repair is associated with poor prognosis. Even unilateral disease may progress to total obstruction in the involved lung. Because intraoperative factors may predispose to generation of PR-PVS, intraoperative strategies to minimize postoperative turbulence may help to reduce the incidence of this lesion.


    Footnotes
 Top
 Footnotes
 Abstract
 Introduction
 Methods
 Results
 Comment
 References
 
This article has been selected for the open discussion forum on the STS Web site: http://www.sts.org/annals


    References
 Top
 Footnotes
 Abstract
 Introduction
 Methods
 Results
 Comment
 References
 

  1. Yee E.S., Turley K., Wen-Ren H., Ebert P.A. Infant total anomalous pulmonary venous connection: factors influencing timing of presentation and operative outcome. Circulation 1987;76(Suppl 3):83-87.
  2. Bando K., Turrentine M.W., Ensing G.J., et al. Surgical management of total anomalous pulmonary venous connection. Circulation 1996;94(Suppl 2):12-16.
  3. Lamb R.K., Qureshi S.A., Wilkinson J.L., Arnold R., West R.W., Hamilton D.I. Total anomalous pulmonary venous drainage: seventeen year surgical experience. J Thorac Cardiovasc Surg 1988;96:368-375.[Abstract]
  4. Sano S., Brawn W.J., Mee R.B. Total anomalous pulmonary venous drainage. J Thorac Cardiovasc Surg 1989;97:886-892.[Abstract]
  5. Van de Wal H.J., Hamilton D.I., Godman M.J., Harinck E., Lacquet L.K., Oort A. Pulmonary venous obstruction following correction for total anomalous pulmonary venous obstruction: a challenge. Eur J Cardiothorac Surg 1992;6:545-549.[Abstract]
  6. Wilson W.R., Ilbawi M.N., DeLeon S.Y., et al. Technical modifications for improved results in total anomalous pulmonary venous drainage. J Thorac Cardiovasc Surg 1992;103:861-871.[Abstract]
  7. Smallhorn J.F., Burrows P., Wilson G., Coles J., Gilday D.L., Freedom R.M. Two dimensional and pulsed Doppler echocardiography in the postoperative evaluation of total anomalous pulmonary venous connection. Circulation 1987;76:298-305.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
RadiologyHome page
A. M. Gaca, J. J. Jaggers, L. T. Dudley, and G. S. Bisset III
Repair of Congenital Heart Disease: A Primer--Part 2
Radiology, July 1, 2008; 248(1): 44 - 60.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. D. McBane II, R. J. Leadley Jr, S. M. Baxi, K. Karnicki, and W. Wysokinski
Iliac Venous Stenting: Antithrombotic Efficacy of PD0348292, an Oral Direct Factor Xa Inhibitor, Compared With Antiplatelet Agents in Pigs
Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 413 - 418.
[Abstract] [Full Text] [PDF]


Home page
MMCTSHome page
J. C. Hirsch and E. L. Bove
Total anomalous pulmonary venous connection
MMCTS, May 7, 2007; 2007(0507): 2253.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Karamlou, R. Gurofsky, E. Al Sukhni, J. G. Coles, W. G. Williams, C. A. Caldarone, G. S. Van Arsdell, and B. W. McCrindle
Factors Associated With Mortality and Reoperation in 377 Children With Total Anomalous Pulmonary Venous Connection
Circulation, March 27, 2007; 115(12): 1591 - 1598.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. A. Latson and L. R. Prieto
Congenital and Acquired Pulmonary Vein Stenosis
Circulation, January 2, 2007; 115(1): 103 - 108.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
I. E. Konstantinov
Primary sutureless repair of total anomalous pulmonary venous connection: The value of intrapleural hilar reapproximation.
J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 729 - 730.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. J. Devaney, A. C. Chang, R. G. Ohye, and E. L. Bove
Management of Congenital and Acquired Pulmonary Vein Stenosis.
Ann. Thorac. Surg., March 1, 2006; 81(3): 992 - 996.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. L. Packer, P. Keelan, T. M. Munger, J. F. Breen, S. Asirvatham, L. A. Peterson, K. H. Monahan, M. F. Hauser, K. Chandrasekaran, L. J. Sinak, et al.
Clinical Presentation, Investigation, and Management of Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation
Circulation, February 8, 2005; 111(5): 546 - 554.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. L. Hancock Friesen, D. Zurakowski, R. R. Thiagarajan, J. M. Forbess, P. J. del Nido, J. E. Mayer, and R. A. Jonas
Total Anomalous Pulmonary Venous Connection: An Analysis of Current Management Strategies in a Single Institution
Ann. Thorac. Surg., February 1, 2005; 79(2): 596 - 606.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T.-J. Yun, J. G. Coles, I. E. Konstantinov, O. O. Al-Radi, R. M. Wald, V. Guerra, N. C. de Oliveira, G. S. Van Arsdell, W. G. Williams, J. Smallhorn, et al.
Conventional and sutureless techniques for management of the pulmonary veins: Evolution of indications from postrepair pulmonary vein stenosis to primary pulmonary vein anomalies
J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 167 - 174.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Mavroudis and R. M. Sade
The Southern Thoracic Surgical Association 50th anniversary celebration: the impact of STSA pediatric cardiothoracic surgery manuscripts on surgical practice
Ann. Thorac. Surg., November 1, 2003; 76(90050): S47 - 67.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C J McMahon, C E Mullins, and H G El Said
Intrastent sonotherapy in pulmonary vein restenosis: a new treatment for a recalcitrant problem
Heart, February 1, 2003; 89(2): e6 - 6.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Giamberti, J. E. Deanfield, R. H. Anderson, and M. R. de Leval
Totally anomalous pulmonary venous connection directly to the superior caval vein
Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 474 - 477.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. D. Thompson, D. B. McElhinney, V. M. Reddy, K. L. Jue, and F. L. Hanley
Infradiaphragmatic totally anomalous pulmonary venous return with two separate descending veins in association with right atrial isomerism
Ann. Thorac. Surg., October 1, 2000; 70(4): 1400 - 1402.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christopher A. Caldarone
Hani K. Najm
William G. Williams
John G. Coles
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caldarone, C. A.
Right arrow Articles by Coles, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caldarone, C. A.
Right arrow Articles by Coles, J. G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS